Bausch + Lomb’s Post

View organization page for Bausch + Lomb, graphic

250,769 followers

#Glaucoma is a condition that can damage the optic nerve and, if left untreated, can lead to permanent vision loss, and even blindness. Derek Cunningham, OD, FAAO, joined Eyes On Eyecare at their annual Eyes on Glaucoma event to share practical insights on using VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, for glaucoma management. Learn more at eyesonglaucoma.com. #SeeBetterLiveBetter #GlaucomaAwareness VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024% is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Increased pigmentation of the iris and periorbital tissue (eyelid) can occur. Iris pigmentation is likely to be permanent. Gradual changes to eyelashes, including increased length, increased thickness, and number of eyelashes, may occur. These changes are usually reversible upon treatment discontinuation. Most common ocular adverse reactions with incidence ≥2% are conjunctival hyperemia (6%), eye irritation (4%), eye pain (3%), and instillation site pain (2%). Please see Important Safety Information at https://lnkd.in/ebB5j6cR and full Prescribing Information (https://lnkd.in/eDEJwEJD) at VYZULTA.com.

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics